We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NUROW market cap is 1.22M. The company's latest EPS is USD -0.7600 and P/E is -5.33.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.66M | 1.2M | 1.32M | 1.09M | 769k |
| Operating Income | -1.62M | -1.96M | -1.86M | -3.26M | -1.83M |
| Net Income | -1.54M | -1.77M | -1.65M | -3.03M | -1.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9.27M | 7.38M | 8.25M | 8.26M | 5.9M |
| Operating Income | -11.53M | -2.1M | -2.29M | -4.74M | -7.15M |
| Net Income | -3.77M | -2.09M | -2.28M | -4.42M | -6.53M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 22.77M | 21.29M | 21.42M | 20.66M | 18.93M |
| Total Liabilities | 1.36M | 1.38M | 1.33M | 1.91M | 1.62M |
| Total Equity | 21.41M | 19.9M | 20.09M | 18.76M | 17.31M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.89M | 8M | 24.89M | 24.67M | 21.42M |
| Total Liabilities | 4.36M | 2.75M | 1.67M | 1.31M | 1.33M |
| Total Equity | 2.53M | 5.25M | 23.22M | 23.36M | 20.09M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.57M | -4.64M | -6.08M | -2.08M | -3.45M |
| Investing | -600k | 1.06M | 1.16M | 138k | 1.85M |
| Financing | 700k | 702k | 2.33M | 1.47M | 1.47M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.62M | -2.07M | -2.07M | -5.29M | -6.08M |
| Investing | -48k | N/A | -132k | -16.89M | 1.16M |
| Financing | 15k | 4.17M | 19.55M | 3.86M | 2.33M |
| Market Cap | 1.22M |
| Price to Earnings Ratio | -5.33 |
| Price to Sales Ratio | 5.9 |
| Price to Cash Ratio | 20.09 |
| Price to Book Ratio | 1.73 |
| Dividend Yield | - |
| Shares Outstanding | 8.59M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.3 (99%) |
| Company Name | NeuroMetrix Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.neurometrix.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
